• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于热休克蛋白70伴侣分子(HSymM)引导的免疫显性p53反式激活结构域推定肽抗原工程,以改善其与抗p53单克隆抗体的结合。

HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibody.

作者信息

Fritz Zachary R, Schloss Rene S, Yarmush Martin L, Williams Lawrence J

机构信息

Department of Biomedical Engineering, Rutgers University, Piscataway, NJ 08854, United States.

Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, United States.

出版信息

Bioorg Med Chem Lett. 2021 Nov 1;51:128341. doi: 10.1016/j.bmcl.2021.128341. Epub 2021 Aug 26.

DOI:10.1016/j.bmcl.2021.128341
PMID:34454062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8526406/
Abstract

A novel engineering strategy to improve autoantibody detection with peptide fragments derived from the parent antigen is presented. The model system studied was the binding of the putative p53 TAD peptide antigen (residues 46-55) to its cognate anti-p53 antibody, ab28. Each engineered peptide contained the full decapeptide epitope and differed only in the flanking regions. Since minimal structural information was available to guide the design, a simple epitope:paratope binding model was applied. The Hidden Symmetry Model, which we recently reported, was used to guide peptide design and estimate per-residue contributions to interaction free energy as a function of added C- and N-terminal flanking peptides. Twenty-four peptide constructs were designed, synthesized, and assessed for binding affinity to ab28 by surface plasmon resonance, and a subset of these peptides were evaluated in a simulated immunoassay for limit of detection. Many peptides exhibited over 200-fold enhancements in binding affinity and improved limits of detection. The epitope was reevaluated and is proposed to be the undecapeptide corresponding to residues 45-55. HSymM calculated binding free energy and experimental data were found to be in good agreement (R > 0.75).

摘要

本文提出了一种新的工程策略,利用源自亲本抗原的肽片段来改进自身抗体检测。所研究的模型系统是假定的p53 TAD肽抗原(第46 - 55位氨基酸残基)与其同源抗p53抗体ab28的结合。每个工程化肽都包含完整的十肽表位,仅侧翼区域不同。由于可用于指导设计的结构信息极少,因此应用了一个简单的表位:互补位结合模型。我们最近报道的隐藏对称性模型用于指导肽设计,并估计作为添加的C端和N端侧翼肽的函数的每个残基对相互作用自由能的贡献。设计、合成了24种肽构建体,并通过表面等离子体共振评估其与ab28的结合亲和力,其中一部分肽在模拟免疫测定中评估了检测限。许多肽的结合亲和力提高了200倍以上,检测限也有所改善。对表位进行了重新评估,提出其为对应于第45 - 55位氨基酸残基的十一肽。发现隐藏对称性模型计算的结合自由能与实验数据吻合良好(R > 0.75)。

相似文献

1
HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibody.基于热休克蛋白70伴侣分子(HSymM)引导的免疫显性p53反式激活结构域推定肽抗原工程,以改善其与抗p53单克隆抗体的结合。
Bioorg Med Chem Lett. 2021 Nov 1;51:128341. doi: 10.1016/j.bmcl.2021.128341. Epub 2021 Aug 26.
2
Characterization of a new intrabody directed against the N-terminal region of human p53.一种针对人p53蛋白N端区域的新型胞内抗体的特性分析
Oncogene. 1998 Nov 12;17(19):2445-56. doi: 10.1038/sj.onc.1202190.
3
A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53.一种针对p53羧基末端多磷酸化构象表位的单克隆抗体。
Biochim Biophys Acta. 1998 Sep 16;1404(3):457-74. doi: 10.1016/s0167-4889(98)00087-1.
4
Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides.使用p53合成肽或噬菌体展示肽通过酶联免疫吸附测定法检测抗p53抗体。
J Immunol Methods. 2002 Jan 1;259(1-2):65-75. doi: 10.1016/s0022-1759(01)00494-x.
5
Critical residues of epitopes recognized by several anti-p53 monoclonal antibodies correspond to key residues of p53 involved in interactions with the mdm2 protein.几种抗p53单克隆抗体识别的表位关键残基,与p53中参与和mdm2蛋白相互作用的关键残基相对应。
J Immunol Methods. 2000 Oct 20;244(1-2):17-28. doi: 10.1016/s0022-1759(00)00246-5.
6
A monoclonal antibody against DNA binding helix of p53 protein.一种针对p53蛋白DNA结合螺旋结构域的单克隆抗体。
Oncogene. 2001 Mar 15;20(11):1398-401. doi: 10.1038/sj.onc.1204240.
7
Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.单克隆抗体能够区分仅在一个化学基团上存在差异的合成肽。
J Immunol. 1987 May 15;138(10):3332-8.
8
Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA.在小鼠中,自发性和诱发性系统性红斑狼疮与针对识别受损DNA的p53 C末端结构域的自身免疫相关。
Eur J Immunol. 2000 Apr;30(4):977-84. doi: 10.1002/(SICI)1521-4141(200004)30:4<977::AID-IMMU977>3.0.CO;2-A.
9
Amino acid modifications in the wild type sequence p53 232-240 overcome the poor immunogenicity of this self tumour epitope.野生型序列p53 232 - 240中的氨基酸修饰克服了这种自身肿瘤表位免疫原性差的问题。
J Pept Sci. 2002 Jul;8(7):327-34. doi: 10.1002/psc.391.
10
Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.人类肿瘤抑制蛋白p53在丝氨酸20和苏氨酸18处的新型磷酸化位点会破坏小鼠双微体2(mdm2)蛋白的结合,这些位点在人类癌症中发生了改变。
Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):133-41.

本文引用的文献

1
A protein interaction free energy model based on amino acid residue contributions: Assessment of point mutation stability of T4 lysozyme.一种基于氨基酸残基贡献的蛋白质相互作用自由能模型:T4溶菌酶点突变稳定性评估
Technology (Singap World Sci). 2019 Mar-Jun;7(1-2):12-39. doi: 10.1142/s233954781950002x. Epub 2019 Apr 26.
2
Peptide-Based Vaccines: Current Progress and Future Challenges.基于肽的疫苗:当前进展和未来挑战。
Chem Rev. 2020 Mar 25;120(6):3210-3229. doi: 10.1021/acs.chemrev.9b00472. Epub 2019 Dec 5.
3
An ELISA-Based Screening Platform for Ligand-Receptor Discovery.一种基于酶联免疫吸附测定的配体-受体发现筛选平台。
Methods Enzymol. 2019;615:453-475. doi: 10.1016/bs.mie.2018.10.001. Epub 2018 Dec 28.
4
Diagnostic Value of Autoantibodies in Lung Cancer: a Systematic Review and Meta-Analysis.自身抗体在肺癌中的诊断价值:一项系统评价与Meta分析
Cell Physiol Biochem. 2018;51(6):2631-2646. doi: 10.1159/000495935. Epub 2018 Dec 11.
5
Modeling of Protein Structural Flexibility and Large-Scale Dynamics: Coarse-Grained Simulations and Elastic Network Models.蛋白质结构柔韧性和大规模动力学建模:粗粒度模拟和弹性网络模型。
Int J Mol Sci. 2018 Nov 6;19(11):3496. doi: 10.3390/ijms19113496.
6
Synthetic Control of Tertiary Helical Structures in Short Peptides.短肽中三级螺旋结构的合成控制。
J Am Chem Soc. 2018 Nov 28;140(47):16284-16290. doi: 10.1021/jacs.8b10082. Epub 2018 Nov 14.
7
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.使用肽搭扣对 T 细胞受体/肽 MHC 亲和力和交叉反应性之间的关系进行压力测试。
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7369-E7378. doi: 10.1073/pnas.1802746115. Epub 2018 Jul 18.
8
Approaches to Improve Chemically Defined Synthetic Peptide Vaccines.提高化学定义合成肽疫苗的方法。
Front Immunol. 2018 Apr 26;9:884. doi: 10.3389/fimmu.2018.00884. eCollection 2018.
9
Leveraging a "Catch-Release" Logic Gate Process for the Synthesis and Nonchromatographic Purification of Thioether- or Amine-Bridged Macrocyclic Peptides.利用“捕获-释放”逻辑门过程合成和非色谱纯化硫醚或胺桥接大环肽。
J Org Chem. 2018 Apr 20;83(8):4323-4335. doi: 10.1021/acs.joc.7b03124. Epub 2018 Apr 3.
10
Therapeutic peptides: Historical perspectives, current development trends, and future directions.治疗性肽:历史视角、当前发展趋势和未来方向。
Bioorg Med Chem. 2018 Jun 1;26(10):2700-2707. doi: 10.1016/j.bmc.2017.06.052. Epub 2017 Jul 1.